10th Anniversary Celebration

Slides:



Advertisements
Similar presentations
David M. Pollock Medical College of Georgia Discovery-Academia.
Advertisements

DRUG DEVELOPMENT The Long Road to a New Medicine
Statistics in the FDA and Industry: Past, Present, and Future Organizers: Ken Koury, Estelle Russek-Cohen, Greg Wei Chair: Mohan Beltangady FDA/Industry.
NHS Chair of Pharmacogenetics
Postgraduate Course in Pharmaceutical Medicine A warm welcome to all participants.
Clinical Bioinformatics: the need for CBAS and SCBC in Applied Sciences? Dr James Mah MBBS(Lon), BSc(Hons,Lon). Chair, CBAS 2009 Singapore
Alternative Careers in Pharma and Biotechnology Douglas Buckley Ph.D. May 13, 2011 Alternative Career Symposium Baylor College of Medicine.
Open Discussions/New Issues Forum/ Future Emphasis of ICORD Meetings Jan-Inge Henter, MD, PhD Professor of Pediatrics Karolinska University Hospital Stockholm,
Prize4Life: Inducement Prizes for ALS (Lou Gehrig’s Disease) Nicole Szlezak Member, Board of Directors Prize4Life.
Nanotechnology in Drug Discovery- Development and Delivery
Discovery of new medicines through new models of collaboration Simon Ward Professor of Medicinal Chemistry & Director of Translational Drug Discovery Group.
Bio-Tech Israel 2005 Conference & Exhibition May 24 – 26, 2005 David Intercontinental Hotel, Tel Aviv, Israel.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke U.S. DEPARTMENT OF HEALTH.
Systems Engineering Research and the Cancer Care Engineering Project Joseph F. Pekny, Ph. D. (Purdue University) Professor of Chemical Engineering Interim.
Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.
Progress in the RNOH-IOMS Joint Academic Strategy David Marsh Professor of Clinical Orthopaedics, Institute of Orthopaedics and Musculoskeletal Science.
This curriculum is available on the NWABR website, Permission granted for educational use ©2012 Northwest Association for Biomedical.
ISPOR Polish Chapter Accomplishments and plans for 2007/2008.
Alessandra Scagliarini Comitato Promotore ITPGAH Alma Mater Studiorum - Università di Bologna Mirror Groups Meeting Brussells 22 September 2009 ITPGAH.
The International Society For Cellular Therapy. Mission Statement ISCT is a global association driving the translation of scientific research to deliver.
Presentation/Phenotype
Highlights Include: Poster Session: over 100 scientific posters displayed throughout the hospital in a variety of areas Mini-Symposia on topics including:
Funding Opportunities Pfizer - Centers for Therapeutic Innovation (CTI) RFA Coming Soon! Information Session: Monday, Sept 10, 1pm, Duncan Reid Conference.
Critical Care Department St. Michael’s Hospital Research Program © 2003 Critical Care Dept, St. Michael’s Hospital.
Submission doc.: IEEE 802-EC-13/0063r0 IEEE 802 Marketing Update Nov 2013 Plenary Date: Nov 2013 John D’Ambrosia, DellSlide 1 Author John D’Ambrosia,
Introduction to Careers in Acute and Ambulatory Settings.
NoWCADD Progress Report 2015
IEEE – Pune Section Industry and Academia Collaboration.
Developing new approaches to treating multi-drug resistant infection “A journey of a thousand miles starts with a single step”- Lao-tzu (604 BC BC)
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.
Synthetic Chemistry for the Life Sciences Dial – a – Molecule Workshop, University of Liverpool Jan-12 Where / how can chemistry make greater contribution.
Interviewing for the Pharmaceutical Industry: what does it involve and how to succeed? David P Brooks.
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
From the Valley of Death to the Bridge of Life: Models for De-Risking Early Translational Projects from Around the World.
Precision Medicine Market share of over 30% dominated by Oncology applications
Moiz Bakhiet, MD, PhD, Professor and Chairman
SciLifeLab DDD Platform – built for function
Hallmarks of Cancer December 11–13, 2016 — Ghent, Belgium
New Approaches to Metabolomics Research
An introduction to personalised medicine & health in Leeds
Could you help us create it ?
This is the text frame you can fill in all your project-related information. Please note: (a) that the following information is mandatory: - project.
Save the Date.
Translating regenerative medicine to the clinic
Can Drug Discovery Research be Done At An Undergraduate Institution?
Trial Innovation Network Uncovering Grand Opportunities
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
ATOM Accelerating Therapeutics for Opportunities in Medicine
Professor Daniel Palmer Chair Medical Oncology NWCR, Dr Syed Hussain Clinical Senior Lecturer, Medical Oncology, University of Liverpool invite you to:
Come and join us at AIMECS racicongress
CM 107 Innovative Education-- snaptutorial.com
A new antivirulence approach against pathogenic bacteria
Immunotherapeutics 18th Annual Research Retreat

RESEARCH & INNOVATION SHOWCASE Alan Morgan, Jeff Barclay, Bob Burgoyne (Physiology) Graeme Sills, Tony Marson (Pharmacology/Walton Centre Neurology) Epilepsy.
Branko Stefanovic Biomedical Sciences
From Data to Therapies Research in Xinghua Lu’s Lab
Innovative Medicines Initiative:
Implementing Genome-Driven Oncology
Publishers of Quality Research
Precision Medicine A New Era Hazem Assi American University of Beirut
Robinson College Cambridge 15-17th April 2019
Coverage and Reimbursement to Genetic Testing
View the latest programme and register at
Volume 21, Issue 9, Pages (September 2014)
The Drosophila pipeline for modeling human disease.
8th Mammalian Genes, Development and Disease Meeting
Keynote Speakers Key Dates
Presentation transcript:

10th Anniversary Celebration Drug Discovery 2016 will bring together 1000 delegates and 50 world-class speakers from academia and industry, each representing critical areas in drug discovery. Scientific Sessions: Innovations in Chemistry Oncology & Immunology Innovations in Predictive & Translational Models Assay Development, Screening & Emerging Technologies Coming Closer to the Patient - Cells & Genes in Therapy & Diagnostics Target Identification & Validation Plenary Keynotes: Professor Munir Pirmohamed David Weatherall Chair in Medicine, Royal Liverpool University Hospital Professor Dame Carol Robinson OBE Professor of Chemistry, University of Oxford To submit an abstract or register, visit: www.elrig.org/drug-discovery-2016

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.